Gabriele Bleckert

2PUBLICATIONS
7CO-AUTHORS
Pharmaceutical delivery technologiesPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 11, 2025
Baseline characteristics in the SYNCHRONIZE™-2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP-1 receptor dual agonist, for obesity in people with type 2 diabetes.

Sean Wharton, Carel W le Roux, Biykem Bozkurt

|Nov 04, 2025
Survodutide for treatment of obesity: Baseline characteristics of participants in a randomized, double-blind, placebo-controlled, phase 3 trial (SYNCHRONIZE™-1).

Carel W le Roux, Sean Wharton, Biykem Bozkurt

Pageof 1

Frequent Collaborators

2 joint publications

Carel W le Roux

2 joint publications

Sean Wharton

2 joint publications

Biykem Bozkurt

2 joint publications

Elke Platz